Market Tracker

11/24 7:02am ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.82
Data as of Nov 21
 -0.025 / -1.36%
Today’s Change
1.53
Today|||52-Week Range
3.79
-40.72%
Year-to-Date
Frontrunning: November 17
Nov 17 / Investing Channel
 

Today’s Trading

Previous close1.85
Today’s open1.88
Day’s range-- - --
Volume29,206
Average volume (3 months)165,627
Market cap$41.8M
Dividend yield--
Data as of 11/21/2014

Growth & Valuation

Earnings growth (last year)+79.49%
Earnings growth (this year)+23.16%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...+0.09+2.11%
ADMPAdamis Pharmaceutica...-0.00-0.01%
GTXIGTX Inc+0.01+1.80%
BLRXBioLine RX Ltd-0.01-0.79%
Data as of 11/21/2014

Financials

Last reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$30.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul F. Truex
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts